A Study With Central Nervous System Metastatic EGFR Mutation Positive Non-small Cell Lung Cancer
ConditionNSCLC
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorHunan Province Tumor Hospital
About this trial
This is a descriptive observational study, in which data are collected in an epidemiological fashion and prospective. This study does not intend to intervene the current medical practice of the recruited patients.
Eligibility criteria
Qualifiers
Patients must be ≥18 years.
Provision of fully informed consent prior to any study specific procedures.
Patient with EGFR 19Del or L858R mutation diagnosed histologically or cytologically. The mutations above may exist alone or together.
Patients must have untreated advanced Non-Small Cell Lung Cancer (NSCLC).
Disqualifiers
None
Trial design
Treatments tested in this trial
- Not listed
Trial groups
No trial groups listed
Sponsors and collaborators
Source ClinicalTrials.gov